Research ArticleTheranostics
Head-to-Head Comparison of 68Ga-PSMA-11 with 18F-PSMA-1007 PET/CT in Staging Prostate Cancer Using Histopathology and Immunohistochemical Analysis as a Reference Standard
Jonathan Kuten, Ibrahim Fahoum, Ziv Savin, Ofer Shamni, Gilad Gitstein, Dov Hershkovitz, Nicola J. Mabjeesh, Ofer Yossepowitch, Eyal Mishani and Einat Even-Sapir
Journal of Nuclear Medicine April 2020, 61 (4) 527-532; DOI: https://doi.org/10.2967/jnumed.119.234187
Jonathan Kuten
1Department of Nuclear Medicine, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel
Ibrahim Fahoum
2Department of Pathology, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel
Ziv Savin
3Department of Urology, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel
Ofer Shamni
4Hadassah Cyclotron Unit, Hadassah Medical Center, Jerusalem, Israel; and
Gilad Gitstein
2Department of Pathology, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel
Dov Hershkovitz
2Department of Pathology, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel
5Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
Nicola J. Mabjeesh
3Department of Urology, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel
5Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
Ofer Yossepowitch
3Department of Urology, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel
5Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
Eyal Mishani
4Hadassah Cyclotron Unit, Hadassah Medical Center, Jerusalem, Israel; and
Einat Even-Sapir
1Department of Nuclear Medicine, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel
5Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel

Data supplements
Supplemental Data
Files in this Data Supplement:
In this issue
Journal of Nuclear Medicine
Vol. 61, Issue 4
April 1, 2020
Head-to-Head Comparison of 68Ga-PSMA-11 with 18F-PSMA-1007 PET/CT in Staging Prostate Cancer Using Histopathology and Immunohistochemical Analysis as a Reference Standard
Jonathan Kuten, Ibrahim Fahoum, Ziv Savin, Ofer Shamni, Gilad Gitstein, Dov Hershkovitz, Nicola J. Mabjeesh, Ofer Yossepowitch, Eyal Mishani, Einat Even-Sapir
Journal of Nuclear Medicine Apr 2020, 61 (4) 527-532; DOI: 10.2967/jnumed.119.234187
Head-to-Head Comparison of 68Ga-PSMA-11 with 18F-PSMA-1007 PET/CT in Staging Prostate Cancer Using Histopathology and Immunohistochemical Analysis as a Reference Standard
Jonathan Kuten, Ibrahim Fahoum, Ziv Savin, Ofer Shamni, Gilad Gitstein, Dov Hershkovitz, Nicola J. Mabjeesh, Ofer Yossepowitch, Eyal Mishani, Einat Even-Sapir
Journal of Nuclear Medicine Apr 2020, 61 (4) 527-532; DOI: 10.2967/jnumed.119.234187
Jump to section
Related Articles
Cited By...
- Limitations of Retrospective Study Design and Potential Bias in the PRECISE-MDT Study
- Diagnostic Performance of [18F]AlF-Thretide PET/CT in Patients with Newly Diagnosed Prostate Cancer Using Histopathology as Reference Standard
- Protocol for SNOTOB study: radical prostatectomy without prostate biopsy following 18F-PSMA-1007 PET/CT based on a diagnostic model: a single-centre, single-arm, open-label study
- Identification of alternative protein targets of glutamate-ureido-lysine associated with PSMA tracer uptake in prostate cancer cells
- Appropriate Use Criteria for Prostate-Specific Membrane Antigen PET Imaging
- Prostate-specific membrane antigen positron emission tomography compared to multiparametric MRI for prostate cancer diagnosis: a protocol for a systematic review and meta-analysis
- Tumor Detection of 18F-PSMA-1007 in the Prostate Gland in Patients with Prostate Cancer Using Prostatectomy Specimens as Reference Method
- Combination of Forced Diuresis with Additional Late Imaging in 68Ga-PSMA-11 PET/CT: Effects on Lesion Visibility and Radiotracer Uptake
- Matched-Pair Comparison of 68Ga-PSMA-11 and 18F-rhPSMA-7 PET/CT in Patients with Primary and Biochemical Recurrence of Prostate Cancer: Frequency of Non-Tumor-Related Uptake and Tumor Positivity
- Diagnostic Performance of 18F-DCFPyL-PET/CT in Men with Biochemically Recurrent Prostate Cancer: Results from the CONDOR Phase III, Multicenter Study
- Intraprostatic Tumor Segmentation on PSMA PET Images in Patients with Primary Prostate Cancer with a Convolutional Neural Network
- Diagnostic Accuracy of 18F-PSMA-1007 PET/CT Imaging for Lymph Node Staging of Prostate Carcinoma in Primary and Biochemical Recurrence
- Factors Predicting Metastatic Disease in 68Ga-PSMA-11 PET-Positive Osseous Lesions in Prostate Cancer